NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 187 filers reported holding NEVRO CORP in Q1 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,508,844 | -19.5% | 130,533 | +6.5% | 0.00% | 0.0% |
| Q2 2023 | $3,116,187 | -27.9% | 122,588 | +2.6% | 0.00% | 0.0% |
| Q1 2023 | $4,320,070 | -10.4% | 119,504 | -1.9% | 0.00% | 0.0% |
| Q4 2022 | $4,821,933 | -30.9% | 121,766 | -18.7% | 0.00% | -50.0% |
| Q3 2022 | $6,983,000 | -52.2% | 149,854 | -55.0% | 0.00% | -33.3% |
| Q2 2022 | $14,610,000 | -41.8% | 333,337 | -3.9% | 0.00% | -40.0% |
| Q1 2022 | $25,085,000 | -13.7% | 346,816 | -3.3% | 0.01% | 0.0% |
| Q4 2021 | $29,076,000 | -32.0% | 358,656 | -2.4% | 0.01% | -37.5% |
| Q3 2021 | $42,778,000 | -28.8% | 367,561 | +1.5% | 0.01% | -33.3% |
| Q2 2021 | $60,045,000 | +20.4% | 362,181 | +1.3% | 0.01% | +20.0% |
| Q1 2021 | $49,851,000 | -17.8% | 357,361 | +2.0% | 0.01% | -23.1% |
| Q4 2020 | $60,624,000 | +27.5% | 350,216 | +2.6% | 0.01% | +8.3% |
| Q3 2020 | $47,552,000 | +18.5% | 341,366 | +1.6% | 0.01% | +9.1% |
| Q2 2020 | $40,124,000 | +25.9% | 335,849 | +5.3% | 0.01% | 0.0% |
| Q1 2020 | $31,874,000 | -23.7% | 318,795 | -10.3% | 0.01% | 0.0% |
| Q4 2019 | $41,794,000 | -8.9% | 355,574 | -33.4% | 0.01% | -15.4% |
| Q3 2019 | $45,871,000 | +40.9% | 533,562 | +6.2% | 0.01% | +44.4% |
| Q2 2019 | $32,562,000 | +16.1% | 502,248 | +11.9% | 0.01% | +12.5% |
| Q1 2019 | $28,052,000 | +45.5% | 448,772 | -9.5% | 0.01% | +33.3% |
| Q4 2018 | $19,275,000 | -29.0% | 495,672 | +4.0% | 0.01% | -14.3% |
| Q3 2018 | $27,163,000 | -17.9% | 476,548 | +14.9% | 0.01% | -22.2% |
| Q2 2018 | $33,105,000 | -13.8% | 414,587 | -6.5% | 0.01% | -18.2% |
| Q1 2018 | $38,423,000 | +48.6% | 443,322 | +18.4% | 0.01% | +57.1% |
| Q4 2017 | $25,854,000 | -17.9% | 374,464 | +8.0% | 0.01% | -22.2% |
| Q3 2017 | $31,505,000 | +256.8% | 346,682 | +192.3% | 0.01% | +350.0% |
| Q2 2017 | $8,829,000 | -33.3% | 118,611 | -16.0% | 0.00% | -50.0% |
| Q1 2017 | $13,229,000 | +43.8% | 141,178 | +11.5% | 0.00% | +33.3% |
| Q4 2016 | $9,197,000 | -41.1% | 126,577 | -15.4% | 0.00% | -40.0% |
| Q3 2016 | $15,622,000 | +35.4% | 149,651 | -4.3% | 0.01% | +25.0% |
| Q2 2016 | $11,539,000 | +50.5% | 156,441 | +14.8% | 0.00% | +100.0% |
| Q1 2016 | $7,666,000 | -15.6% | 136,261 | +1.3% | 0.00% | -33.3% |
| Q4 2015 | $9,085,000 | +52.0% | 134,553 | +4.4% | 0.00% | +50.0% |
| Q3 2015 | $5,978,000 | -14.9% | 128,853 | -1.4% | 0.00% | 0.0% |
| Q2 2015 | $7,026,000 | +104.1% | 130,709 | +82.0% | 0.00% | +100.0% |
| Q1 2015 | $3,442,000 | +204.9% | 71,816 | +146.0% | 0.00% | – |
| Q4 2014 | $1,129,000 | – | 29,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |